Novamed, Ltd.

Novamed, Ltd. is a privately owned Israeli life science company founded in December 1995 with its North American offices located in the USA in the state of Indiana. Since its inception, Novamed has been committed to the development of innovative, proprietary diagnostic systems with worldwide marketing potential. Novamed has become an important player in selected markets by combining user need for a particular application with a cost-effective product. Such products include the patented and FDA approved DipStreak® and Diaslide® culture devices for rapid diagnosis of urinary tract infections and NovaStreak® for detection of microorganisms present in food and dairy products. In addition to high quality, innovative microbiology products, Novamed manufactures a range of new generation imunodiagnostic and cell biology research products. Most of the compnay's 180 products are direct, easy-to-use, one-step, highly sensitive tests with minimal specimen manipulation and results are obtained in only 5 min. All Novamed's products are performance tested in a stringent quality control program, according to ISO 9001:2000 standards. Novamed maintains a staff of 60 employees engaged in research, development, manufacturing, and sales. The President & CEO, Vice-President for Marketing, Vice President and General Manager for North America and company department heads are PhDs, with extensive experience in the fields of biochemistry, immunology, clinical and theoretical microbiology and medical/IVD market development.